Inhibition of monoamine oxidase by palmatine

Archives of Pharmacal Research

Volumn 22, Issue 5, 1999, Pages 529-531

  Lee, Sang Seon ^a   Kim, Young Ho ^b   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BERBERINE DERIVATIVE; KYNURAMINE; MONOAMINE OXIDASE INHIBITOR; PALMATINE;

ANIMAL; ARTICLE; BRAIN; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MITOCHONDRION; MOUSE; ULTRASTRUCTURE;

ANIMALS; BERBERINE ALKALOIDS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; KYNURAMINE; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS;

EID: 0033202928     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02979165     Document Type: Article

References (21)

1. Bembenek, M. E., Abell, C. W., Chrisey, L. A., Rozwadowska, M. D., Gessner, W. and Brossi, A., Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4 -tetrahydro-, 3,4-dihydro- and fully aromatic isoquinolines. J. Med. Chem., 33, 147-152 (1990).
2. Chen, S. H. and Sha, N. H., Dose dependent relationship of analgesic effect of Corydalis app. (Papaveraceae) in mice. Chin. J. Pharm. Anal., 4, 162-163 (1984).
3. Giovine, A., Renis, M. and Bertolino, A., In vivo and in vitro studies on the effect of tetrahydropa paveroline and salsolinol on COMT and MAO activity in rat brain. Pharmacol., 14, 86-94 (1976).
4. Gudima, S. O., Memelova, L. V., Borodulin, V. B., Pokholok, D. K., Mednikov, B. M., Tolkachev, O. N. and Kochetkov, S. N., Kinetic analysis of interaction of human immunodeficiency virus reverse transcriptase with alkaloids. Molekul. Biolog. (Russia), 28, 1308-1314 (1994).
5. Hsieh, M. -T., Su, S. -H., Tsai, H. -Y., Peng, W. -T., Hsieh, C. -C. and Chen, C. -F., Effects of palmatine on motor activity and the concentration of central monoamines and its metabolites in rats. Japan J. Pharmacol., 61, 1-5 (1993).
6. Kraml M., A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol., 14, 1684-1685 (1965).
7. Kuo, C. L., Chou, C. C. and Yung, B. Y. M., Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett., 93, 193-200 (1995).
8. Lee, M. K. and Kim, H. S., Inhibitory effects of the protoberberine alkaloids from the root of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med., 62, 31-34 (1996).
9. Lee, M. K., Zhang, Y. H. and Kim, H. S., Inhibition of tyrosine hydroxylase by palmatine. Arch. Pharm. Res., 19, 258-260 (1996).
10. Lee, S. S., Yoon-Choi, H. S., Kim, E. I. and Lee, M. K., Inhibition of monoamine oxidase by higenamine. Med. Sci. Res., 27, 71-72 (1999).
11. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
12. Ma, S. S., Chen, K. G., Ma, Y. L. and Bau, S. F., Screening test of antiarrythmia effect of Corydalis turtschaninovii (Papaveraceae) in rats. Bull. Chin. Materia Med., 10, 41-42 (1985).
13. Mazouz, F., Gueddari, S., Burstein, C., Mansuy, D. and Milcent, R., 5-(4-Benzyloxyphenyl)-1,3,4-oxadiazol-2 (3H)-one derivatives and related analogues: new reversible, highly potent, and selective monoamine oxidase type B inhibitors. J. Med. Chem., 36, 1157-1167 (1993).
14. Naoi, M. and Nagatsu, T., Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds. J. Neurochem., 50, 1105-1110 (1988).
15. Naoi, M., Takahashi, T., Darrez, H., Kabeya, R. and Taguchi, E., N-Methylisoquinolinim ion as an inhibitor of tyrosine hydroxylase, aromatic L-amino acid decarboxylase and monoamine oxidase. Neurochem. Int., 15, 315-320 (1989).
16. Strolin-Benedetti, M. and Dostert, P. L., Overview of the present state of MAO inhibitors. J. Neural Transm. (Suppl), 23, 103-119 (1987).
17. Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Wagner, H. and Hostettmann, K., Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 42, 17-21 (1981).
18. Thull, U. and Testa, B., Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases. Biochem. Pharmacol., 47, 2307-2310 (1994).
19. Tipton, K. F., O'Carroll, A. M. and McCrodden, J. M., The catalytic behavior of monoamine oxidase. J. Neural Transm. (Suppl), 23, 25-35 (1987).
20. Vennerstrom, J. L. and Klayman, D. L., Protoberberine alkaloids as antimalarials. J. Med. Chem., 31, 1084-1087 (1988).
21. White, H. L. and Scates, P., Mechanism of monoamine oxidase-A inhibition by BW 1370U87. Drug Dev. Res., 25, 191-199 (1992).